1-9 of 9
M Jesús Blanchard
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Definitive Results of a Randomized Phase 3 Pethema/GEM Study

Laura Rosinol Dachs, Albert Oriol, MD, Ana Isabel Teruel, MDcal Doctor, Ana López de la Guía, M Jesús Blanchard, Isidro Jarque, Miquel Granell, MD, Antonia Sampol, Luis Palomera, MD PhD, Yolanda Gonzalez-Montes, Enrique Bengoechea, Rafael Martínez-Martínez, Miguel T Hernández, MD PhD, Felipe De Arriba, PhD, Maria Luisa Martin-Ramos, Norma C. Gutierrez, MD PhD, Maria Teresa Cibeira, MD PhD, Maria-Victoria Mateos, MD PhD, Joaquin Martinez-Lopez, MD PhD, Adrián Alegre, MD, Juan Jose Lahuerta, MD PhD, Jesus F San-Miguel, MD PhD, Joan Blade, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 126.
https://doi.org/10.1182/blood-2018-99-111924
Published: 2018
Journal Articles

Immune Predictors of Response to Pembrolizumab Monotherapy As Consolidation in Multiple Myeloma Patients: Results of the GEM-Pembresid Clinical Trial

Enrique M. Ocio, MDPhD, Noemi Puig, MD PhD, Luis Corchete, José J Pérez, Julio Dávila, Teresa Paíno, Javier de la Rubia, Albert Oriol, MD, Jesús Martín, Felipe De Arriba, PhD, Joan Bladé, MD PhD, M Jesús Blanchard, Ramón García-Sanz, MD, Bruno Paiva, PhD, Juan-José Lahuerta, Jesus F. San Miguel, MD, Maria-Victoria Mateos, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1874.
https://doi.org/10.1182/blood.V130.Suppl_1.1874.1874
Published: 2017
Journal Articles

Bortezomib, Lenalidomide and Dexamethasone (VRD-GEM) As Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) in Multiple Myeloma (MM): Results of a Prospective Phase III Pethema/GEM Trial

Laura Rosinol, MD PhD, Albert Oriol, MD, Rafael Rios, Anna Sureda, MD PhD, M Jesús Blanchard, Miguel T Hernández, Rafael Martínez-Martínez, Jose M Moraleda, Isidro Jarque, Juan Bargay, Mercedes Gironella, Dra., Maria José Moreno, Luis Palomera, Yolanda Gonzalez-Montes, Josep M Marti, Isabel Krsnik, Jose M Arguiñano, Maria Esther González, Ana Pilar González, Felipe Casado, Lucía Lopez-Anglada, Bruno Paiva, PhD, Maria-Victoria Mateos, MD PhD, Jesus F. San Miguel, MD, Juan-José Lahuerta, Joan Blade, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2017.
https://doi.org/10.1182/blood.V130.Suppl_1.2017.2017
Published: 2017
Journal Articles

Impact of Next-Generation Flow (NGF) Minimal Residual Disease (MRD) Monitoring in Multiple Myeloma (MM): Results from the Pethema/GEM2012 Trial

Bruno Paiva, PhD, Noemi Puig, MD PhD, Maria Teresa Cedena, Lourdes Cordon, Maria-Belen Vidriales, Leire Burgos, Juan Flores-Montero, Lucía Lopez-Anglada, Norma Gutierrez, MD PhD, Maria Jose Calasanz, BSc, PhD, Maria Luisa Martin-Ramos, Ramon Garcia-Sanz, MD PhD, Joaquin Martinez-Lopez, MD PhD, Albert Oriol, MD, M Jesús Blanchard, Rafael Rios, Jesús Martín, Rafael Martínez, Josep Sarra, Miguel T Hernández, Javier de la Rubia, Isabel Krsnik, Jose M Moraleda, Luis Palomera, Juan Bargay, Alberto Orfao, MD PhD, Laura Rosinol, MD PhD, Maria-Victoria Mateos, MD, Juan-José Lahuerta, Joan Bladé, MD PhD, Jesus F. San Miguel, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 905.
https://doi.org/10.1182/blood.V130.Suppl_1.905.905
Published: 2017
Journal Articles

Kinetics of Response to Bortezomib/Thalidomide/Dexamethasone (VTD) in Multiple Myeloma: Implications for the Choice and Design of Pretransplantation Induction Regimens

Laura Rosiñol, MD PhD, Albert Oriol, MD, Ana Isabel Teruel, Dolores Hernández, M Jesús Blanchard, Javier De La Rubia, Miquel Granell, MD, Juan Besalduch, Luis Palomera, Yolanda Gonzalez, Etxebeste Mª Asunción, Joaquín Díaz-Mediavilla, Miguel T. Hernandez, Felipe de Arriba, Norma Carmen Gutierrez, PhD MD, Maria-Victoria Mateos, MD PhD, Joaquin Martinez-Lopez, MD PhD, Adrian Alegre, MD, Huaibao Feng, Helgi van de Velde, Juan José Lahuerta, MD PhD, Jesus F. San Miguel, Joan Blade
Journal: Blood
Blood (2014) 124 (21): 2108.
https://doi.org/10.1182/blood.V124.21.2108.2108
Published: 2014
Journal Articles

Tumor and Renal Response in Patients with Newly Diagnosed Multiple Mieloma and Renal Failure Treated with Bortezomib and Dexamethasone: Results of a Prospective Phase II Trial from Pethema/GEM

Laura Rosiñol, MD PhD, Albert Oriol, MD, M Jesús Blanchard, Luis Palomera, Maria-Victoria Mateos, Javier De La Rubia, Miguel T Hernandez, MD, Joaquín Díaz-Mediavilla, Jose Mariano Hernandez, Raquel Jiménez, MD, Cristina Motllo, Juan José Lahuerta, MD PhD, Jesus F. San Miguel, Joan Blade
Journal: Blood
Blood (2014) 124 (21): 4776.
https://doi.org/10.1182/blood.V124.21.4776.4776
Published: 2014
Journal Articles

Persistent Benefit of VTD (Bortezomib/Thalidomide/Dexamethasone) As Pretransplant Induction Therapy for Multiple Myeloma: Long-Term Follow-up of a Randomized Phase 3 Pethema/GEM Study

Laura Rosiñol, MD PhD, Albert Oriol, MD, Ana Isabel Teruel, MD, Dolores Hernandez, M Jesús Blanchard, Javier De La Rubia, Miquel Granell, MD, Juan Besalduch, MD PhD, Luis Palomera, Yolanda Gonzalez, M Asunción Echebeste, Joaquín Díaz-Mediavilla, Miguel T Hernandez, MD, Felipe de Arriba, Norma Carmen Gutierrez, PhD MD, M Luisa Martín-Ramos, M Teresa Cibeira, Maria Victoria Mateos, Joaquin Martinez-Lopez, MD PhD, Adrian Alegre, MD, Juan José Lahuerta, MD PhD, Jesus F. San Miguel, Joan Blade
Journal: Blood
Blood (2014) 124 (21): 3457.
https://doi.org/10.1182/blood.V124.21.3457.3457
Published: 2014
Journal Articles

Phase III Trial Of Bortezomib, Melphalan, and Prednisone (VMP) Versus Bortezomib, Thalidomide, and Prednisone (VTP) In Elderly Multiple Myeloma (MM) Patients: Update Follow-Up, Patterns Management Of First Relapse/Progression

Aurelio Lopez, MD, Marta Valero, Ph, Jose Ignacio Lorenzo, MD, PhD, Maria-Victoria Mateos, MD, PhD, Albert Oriol, MD, Martínez Joaquin, Montserrat Perez, MD, Rafael Martinez, MD, Raquel de Paz, MD, Miguel Granell, MD, Felipe De Arriba, M. Jesús Blanchard, MD, Francisco Javier Peñalver, Jose Luis Bello, MD, Maria Luisa Martin, MD, Joan Bargay, MD, Joan Blade, MD, Juan Jose Lahuerta, MD, Jesús F. San Miguel, MD, PhD, Javier De La Rubia, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 1973.
https://doi.org/10.1182/blood.V122.21.1973.1973
Published: 2013
Journal Articles

Characteristics and Outcome Of 66 Patients With Extramedullary Plasmacytomas (EMPs) Included In a Phase III Pethema/GEM Study Of Induction Therapy Prior Autologous Stem Cell Transplantation (ASCT) In Multiple Myeloma (MM)

Laura Rosiñol, MD, Raquel Jiménez-Segura, Ana Isabel Teruel, MD, Javier De La Rubia, MD, PhD, Maria Victoria Mateos, MD, PhD, Miguel T. Hernandez, Dolores Hernández, M Jesús Blanchard, Belén Iñigo, Luis Palomera, MD, Isabel Krsnik, MD, PhD, Jose Francisco Tomas, MD, Norma C. Gutiérrez, Jesús F. San Miguel, MD, PhD, Juan José Lahuerta, Joan Blade, MD
Journal: Blood
Blood (2013) 122 (21): 3188.
https://doi.org/10.1182/blood.V122.21.3188.3188
Published: 2013